Anterior cervical discectomy and fusion (ACDF) is the most commonly used decompressive procedure in the cervical spine and is used for the treatment of single or multiple level disc disease.

Arthritis & Rheumatism. 2006;54(12):3859-3867. Degenerative disc disease is one of today's most common and costly medical conditions. Marked by the gradual erosion of cartilage between the ...

The researchers developed novel contrast agents that target two proteins implicated in osteoarthritis, a degenerative joint disease commonly ... hinges on a relatively new technology, the photon ...

offering a new therapeutic ... A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder ...

The U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance to a standalone lateral lumbar interbody fusion ...

As the disease progresses, patients lose the ability to talk, walk, swallow and concentrate. Most patients die within 10 to 20 years after symptoms first appear. The new treatment leverages ...

Dr. Graff-Radford's Memory Disorders Lab is studying large cohorts of Caucasian and African American people with Alzheimer's disease, Lewy body dementia, frontotemporal dementia and many controls with ...

Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...

Little Gregory had a severe form of a rare genetic disorder called Gaucher disease and died after ... genes dropped in mice that received the new treatment. These findings were confirmed by ...

The rate of non-Hodgkin's lymphoma has nearly doubled since the 1970s, but advances in treatments ... new weapon and believed Rituxan would work not just on relapsed lymphoma, but on early disease ...

Theradaptive, a privately held, clinical stage biologics company developing targeted protein therapeutics for spine, orthopedics, soft tissue repair and targeted immuno-oncology, today announced the ...